Trial Profile
Phase 2b, Multicenter, Randomized, Double Blind, Titration Trial for Efficacy and Safety of HDV Insulin Lispro in Combination With a Basal Insulin Versus Insulin Lispro in Combination With a Basal Insulin in Patients With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin detemir; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ISLE-1
- Sponsors Diasome Pharmaceuticals
- 12 Feb 2020 According to Diasome media release, results from this trial will be presented as ePoster at the Advanced Technologies & Treatment for Diabetes International (ATTD) Conference, which is being held February 19-22, 2020 in Madrid, Spain.
- 24 Sep 2019 Results presented in the Diasome Pharmaceuticals media release.
- 24 Sep 2019 Primary endpoint (Change in HbA1c) has been met, according to the results published in the Diabetes Care.